Comparative Analysis of 2 Calcium Silicate-based Cements (Biodentine and Mineral Trioxide Aggregate) as Direct Pulp-capping Agent in Young Permanent Molars: A Split Mouth Study

J Endod. 2017 Apr;43(4):507-513. doi: 10.1016/j.joen.2016.11.026. Epub 2017 Feb 16.

Abstract

Introduction: The purpose of this study was to compare Biodentine and mineral trioxide aggregate (MTA) for direct pulp capping in young permanent molars by clinical and radiographic evaluation in 7- to 9-year-old children.

Methods: In 50 patients, 29 patients with bilateral asymptomatic first permanent molars with carious involvement were selected. According to split mouth design, these patients were then divided into 2 groups, Biodentine group (right side) and MTA group (left side). The pulp-capping procedure was performed by using Biodentine and MTA in 58 asymptomatic bilateral permanent molars with pulp exposure. At each recall (baseline, 6 and 12 months), treatment outcome was assessed clinically through pulpal sensitivity tests as well as radiographically to evaluate dentin bridge formation.

Results: The study reported 100% success rate with both Biodentine and MTA at baseline and 6- and 12-month follow-up on the basis of clinical and radiographic parameters. These findings were statistically non-significant (P < .05) between both groups (Biodentine and MTA). Radiographically, dentin bridge formation was not evident with both groups at baseline, but it was evident after 6- and 12-month follow-up. These findings were statistically non-significant (P < .05) in both Biodentine and MTA groups.

Conclusions: This study reported 100% success rate with both MTA and Biodentine when used as direct pulp-capping agent in first permanent molars in 7- to 9-year-old children. The major limitations of the study were smaller sample size and short follow-up period.

Keywords: Biodentine; MTA; dentin bridge; direct pulp capping; permanent molars.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aluminum Compounds / therapeutic use*
  • Calcium Compounds / therapeutic use*
  • Child
  • Dental Caries / surgery
  • Dental Pulp Capping / methods*
  • Drug Combinations
  • Female
  • Humans
  • Male
  • Molar / surgery*
  • Oxides / therapeutic use*
  • Pulp Capping and Pulpectomy Agents / therapeutic use*
  • Silicates / therapeutic use*
  • Treatment Outcome

Substances

  • Aluminum Compounds
  • Calcium Compounds
  • Drug Combinations
  • Oxides
  • Pulp Capping and Pulpectomy Agents
  • Silicates
  • mineral trioxide aggregate
  • tricalcium silicate